Korean Journal of Radiology

The Korean Society of Radiology (대한영상의학회)
권호 표지
DOI QR코드

DOI QR Code

Interstitial Lung Abnormalities: What Radiologists Should Know

  • Kum Ju Chae (Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital) ;
  • Gong Yong Jin (Department of Radiology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital) ;
  • Jin Mo Goo (Department of Radiology, Seoul National University College of Medicine) ;
  • Myoung Ja Chung (Department of Pathology, Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital)
  • Received : 2020.02.28
  • Accepted : 2020.08.11
  • Published : 2021.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Interstitial lung abnormalities (ILAs) are radiologic abnormalities found incidentally on chest CT that are potentially related to interstitial lung diseases. Several articles have reported that ILAs are associated with increased mortality, and they can show radiologic progression. With the increased recognition of ILAs on CT, the role of radiologists in reporting them is critical. This review aims to discuss the clinical significance and radiologic characteristics of ILAs to facilitate and enhance their management.

Keywords

References

  1. Hatabu H, Hunninghake GM, Lynch DA. Interstitial lung abnormality: recognition and perspectives. Radiology 2019;291:1-3 https://doi.org/10.1148/radiol.2018181684
  2. Hobbs BD, Putman RK, Araki T, Nishino M, Gudmundsson G, Gudnason V, et al. Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2019;200:1402-1413 https://doi.org/10.1164/rccm.201903-0511OC
  3. Wells AU, Kokosi MA. Subclinical interstitial lung abnormalities: toward the early detection of idiopathic pulmonary fibrosis? Am J Respir Crit Care Med 2016;194:1445-1446 https://doi.org/10.1164/rccm.201607-1363ED
  4. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, Loyd JE, et al. A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 2011;364:1503-1512 https://doi.org/10.1056/NEJMoa1013660
  5. Doyle TJ, Hunninghake GM, Rosas IO. Subclinical interstitial lung disease: why you should care. Am J Respir Crit Care Med 2012;185:1147-1153 https://doi.org/10.1164/rccm.201108-1420PP
  6. Walsh SLF, Richeldi L. Subclinical interstitial lung abnormalities: lumping and splitting revisited. Am J Respir Crit Care Med 2019;200:121-123 https://doi.org/10.1164/rccm.201901-0180ED
  7. Fraser RG, Fraser RS, Renner JW, Bernard C, Fitzgerald PJ. The roentgenologic diagnosis of chronic bronchitis: a reassessment with emphasis on parahilar bronchi seen endon. Radiology 1976;120:1-9 https://doi.org/10.1148/120.1.1
  8. Aberle DR, DeMello S, Berg CD, Black WC, Brewer B, Church TR, et al. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med 2013;369:920-931 https://doi.org/10.1056/NEJMoa1208962
  9. Lederer DJ, Enright PL, Kawut SM, Hoffman EA, Hunninghake G, van Beek EJ, et al. Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study. Am J Respir Crit Care Med 2009;180:407-414 https://doi.org/10.1164/rccm.200812-1966OC
  10. Washko GR, Hunninghake GM, Fernandez IE, Nishino M, Okajima Y, Yamashiro T, et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011;364:897-906 https://doi.org/10.1056/NEJMoa1007285
  11. Tsushima K, Sone S, Yoshikawa S, Yokoyama T, Suzuki T, Kubo K. The radiological patterns of interstitial change at an early phase: over a 4-year follow-up. Respir Med 2010;104:1712-1721 https://doi.org/10.1016/j.rmed.2010.05.014
  12. Oldham JM, Adegunsoye A, Khera S, Lafond E, Noth I, Strek ME, et al. Underreporting of interstitial lung abnormalities on lung cancer screening computed tomography. Ann Am Thorac Soc 2018;15:764-766 https://doi.org/10.1513/AnnalsATS.201801-053RL
  13. Tzilas V, Bouros D. Interstitial lung abnormalities: a word of caution. Chest 2019;156:1037-1038 https://doi.org/10.1016/j.chest.2019.08.2170
  14. Jin GY, Lynch D, Chawla A, Garg K, Tammemagi MC, Sahin H, et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013;268:563-571 https://doi.org/10.1148/radiol.13120816
  15. Araki T, Putman RK, Hatabu H, Gao W, Dupuis J, Latourelle JC, et al. Development and progression of interstitial lung abnormalities in the Framingham Heart Study. Am J Respir Crit Care Med 2016;194:1514-1522 https://doi.org/10.1164/rccm.201512-2523OC
  16. Putman RK, Gudmundsson G, Axelsson GT, Hida T, Honda O, Araki T, et al. Imaging patterns are associated with interstitial lung abnormality progression and mortality. Am J Respir Crit Care Med 2019;200:175-183 https://doi.org/10.1164/rccm.201809-1652OC
  17. Ley B, Collard HR. Epidemiology of idiopathic pulmonary fibrosis. Clin Epidemiol 2013;5:483-492
  18. Sverzellati N, Guerci L, Randi G, Calabro E, La Vecchia C, Marchiano A, et al. Interstitial lung diseases in a lung cancer screening trial. Eur Respir J 2011;38:392-400 https://doi.org/10.1183/09031936.00201809
  19. Putman RK, Hatabu H, Araki T, Gudmundsson G, Gao W, Nishino M, et al. Association between interstitial lung abnormalities and all-cause mortality. JAMA 2016;315:672-681 https://doi.org/10.1001/jama.2016.0518
  20. Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, Latourelle JC, et al. MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 2013;368:2192-2200 https://doi.org/10.1056/NEJMoa1216076
  21. Hoyer N, Wille MMW, Thomsen LH, Wilcke T, Dirksen A, Pedersen JH, et al. Interstitial lung abnormalities are associated with increased mortality in smokers. Respir Med 2018;136:77-82
  22. Washko GR, Lynch DA, Matsuoka S, Ross JC, Umeoka S, Diaz A, et al. Identification of early interstitial lung disease in smokers from the COPDGene Study. Acad Radiol 2010;17:48-53 https://doi.org/10.1016/j.acra.2009.07.016
  23. Hunninghake GM. Interstitial lung abnormalities: erecting fences in the path towards advanced pulmonary fibrosis. Thorax 2019;74:506-511 https://doi.org/10.1136/thoraxjnl-2018-212446
  24. Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J 2016;48:179-186 https://doi.org/10.1183/13993003.01653-2015
  25. Strongman H, Kausar I, Maher TM. Incidence, prevalence, and survival of patients with idiopathic pulmonary fibrosis in the UK. Adv Ther 2018;35:724-736 https://doi.org/10.1007/s12325-018-0693-1
  26. Yoon SH, Hong J, Hwang EJ, Kim H, Lim HJ, Suh YJ, et al. Significant abnormalities other than lung cancer in Korean lung cancer CT screening. J Korean Soc Radiol 2019;80:837-848 https://doi.org/10.3348/jksr.2019.80.5.837
  27. Putman RK, Rosas IO, Hunninghake GM. Genetics and early detection in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2014;189:770-778 https://doi.org/10.1164/rccm.201312-2219PP
  28. Araki T, Dahlberg SE, Hida T, Lydon CA, Rabin MS, Hatabu H, et al. Interstitial lung abnormality in stage IV non-small cell lung cancer: a validation study for the association with poor clinical outcome. Eur J Radiol Open 2019;6:128-131 https://doi.org/10.1016/j.ejro.2019.03.003
  29. Im Y, Park HY, Shin S, Shin SH, Lee H, Ahn JH, et al. Prevalence of and risk factors for pulmonary complications after curative resection in otherwise healthy elderly patients with early stage lung cancer. Respir Res 2019;20:136
  30. Kadoch M, Kitich A, Alqalyoobi S, Lafond E, Foster E, Juarez M, et al. Interstitial lung abnormality is prevalent and associated with worse outcome in patients undergoing transcatheter aortic valve replacement. Respir Med 2018;137:55-60 https://doi.org/10.1016/j.rmed.2018.02.017
  31. Whittaker Brown SA, Padilla M, Mhango G, Powell C, Salvatore M, Henschke C, et al. Interstitial lung abnormalities and lung cancer risk in the national lung screening trial. Chest 2019;156:1195-1203
  32. Remy-Jardin M, Remy J, Gosselin B, Becette V, Edme JL. Lung parenchymal changes secondary to cigarette smoking: pathologic-CT correlations. Radiology 1993;186:643-651 https://doi.org/10.1148/radiology.186.3.8430168
  33. Hansell DM. Thin-section CT of the lungs: the Hinterland of normal. Radiology 2010;256:695-711 https://doi.org/10.1148/radiol.10092307
  34. Lee KN, Yoon SK, Sohn CH, Choi PJ, Webb WR. Dependent lung opacity at thin-section CT: evaluation by spirometrically-gated CT of the influence of lung volume. Korean J Radiol 2002;3:24-29
  35. Otake S, Takahashi M, Ishigaki T. Focal pulmonary interstitial opacities adjacent to thoracic spine osteophytes. AJR Am J Roentgenol 2002;179:893-896 https://doi.org/10.2214/ajr.179.4.1790893
  36. Watadani T, Sakai F, Johkoh T, Noma S, Akira M, Fujimoto K, et al. Interobserver variability in the CT assessment of honeycombing in the lungs. Radiology 2013;266:936-944 https://doi.org/10.1148/radiol.12112516
  37. Chae KJ, Jin GY, Jung HN, Kwon KS, Choi H, Lee YC, et al. Differentiating smoking-related interstitial fibrosis (SRIF) from usual interstitial pneumonia (UIP) with emphysema using CT features based on pathologically proven cases. PLoS One 2016;11:e0162231
  38. Otani H, Tanaka T, Murata K, Fukuoka J, Nitta N, Nagatani Y, et al. Smoking-related interstitial fibrosis combined with pulmonary emphysema: computed tomography-pathologic correlative study using lobectomy specimens. Int J Chron Obstruct Pulmon Dis 2016;11:1521-1532 https://doi.org/10.2147/COPD.S107938
  39. Watanabe Y, Kawabata Y, Kanauchi T, Hoshi E, Kurashima K, Koyama S, et al. Multiple, thin-walled cysts are one of the HRCT features of airspace enlargement with fibrosis. Eur J Radiol 2015;84:986-992
  40. Miller ER, Putman RK, Vivero M, Hung Y, Araki T, Nishino M, et al. Histopathology of interstitial lung abnormalities in the context of lung nodule resections. Am J Respir Crit Care Med 2018;197:955-958 https://doi.org/10.1164/rccm.201708-1679LE